These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1239 related items for PubMed ID: 16882814

  • 1. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC, Modlin JF.
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [Abstract] [Full Text] [Related]

  • 2. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L, Birkhead G, Guerra F, Helms C, Hinman A, Katz S, LeBaron CW, Modlin J, Murphy TV, National Vaccine Advisory Committee-Advisory Committee on Immunization Practices Joint Working Group, Centers for Disease Control and Prevention.
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [Abstract] [Full Text] [Related]

  • 3. Polio control after certification: major issues outstanding.
    Fine PE, Oblapenko G, Sutter RW.
    Bull World Health Organ; 2004 Jan; 82(1):47-52. PubMed ID: 15106300
    [Abstract] [Full Text] [Related]

  • 4. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001 Jan; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 5. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V, Kyriakopoulou Z, Markoulatos P.
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [Abstract] [Full Text] [Related]

  • 6. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J.
    Dev Biol Stand; 1979 May; 43():151-7. PubMed ID: 230106
    [Abstract] [Full Text] [Related]

  • 7. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM, Sutter RW.
    Clin Infect Dis; 2001 Aug 15; 33(4):531-41. PubMed ID: 11462191
    [Abstract] [Full Text] [Related]

  • 8. Risk management in a polio-free world.
    Bruce Aylward R, Sutter RW, Cochi SL, Thompson KM, Jafari H, Heymann D.
    Risk Anal; 2006 Dec 15; 26(6):1441-8. PubMed ID: 17184391
    [Abstract] [Full Text] [Related]

  • 9. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z.
    Przegl Epidemiol; 2005 Dec 15; 59(1):59-68. PubMed ID: 16013411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Worldwide eradication of poliomyelitis].
    Rasch G, Schreier E, Kiehl W, Kurth R.
    Wien Klin Wochenschr; 2001 Oct 30; 113(20-21):839-45. PubMed ID: 11732120
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.
    Duintjer Tebbens RJ, Pallansch MA, Wassilak SG, Cochi SL, Thompson KM.
    BMC Infect Dis; 2016 Mar 24; 16():137. PubMed ID: 27009272
    [Abstract] [Full Text] [Related]

  • 16. Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Feb 03; 55(4):97-9. PubMed ID: 16456525
    [Abstract] [Full Text] [Related]

  • 17. Possible global strategies for stopping polio vaccination and how they could be harmonized.
    Cochi SL, Sutter RW, Aylward RB.
    Dev Biol (Basel); 2001 Feb 03; 105():153-8; discussion 159. PubMed ID: 11763323
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.
    Saleem AF, Yousafzai MT, Mach O, Khan A, Quadri F, Weldon WC, Oberste MS, Zaidi SS, Alam MM, Sutter RW, Zaidi AKM.
    Vaccine; 2018 Mar 20; 36(13):1766-1771. PubMed ID: 29477307
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.